@goedy
Cmon man, gimme something. If you can't beat them, join them?
We are now on the same side. Let's go hard.
I too post here for the new investors. Who looks back a year or more in announcements to find out what's been happening? Not many.
We are doing the right thing and we have the evidence and experience to help potential/new investors make a more informed decision.
We have tried so hard to convince @josiejow37 that RHY and everything that comes with it is rubbish but she believes COLOSTAT is so far ahead of other organisations that offer either FDA or CLIA approved CRC blood tests (protein based or DNA).
This does not make sense in my opinion. COLOSTAT is neither TGA, FDA nor CLIA approved. In jurisdictions such as NZ and EU it is my opinion that the company is not being transparent. Shareholders are being kept in the dark about future plans for these 2 markets that they say that they can sell into.
WHY T F would you want to put money into this C of a stock? They have done FA last quarter.
Not enough volume to close out @ShmoShady ? Wink wink.
@Tobybreslin I had seen it. Likely a mate or mate of a mate. That's how it works in small cap rubbish stocks.
- Forums
- ASX - By Stock
- RHY
- Ann: Dr David Atkins appointed Chief Executive Officer of Rhythm
Ann: Dr David Atkins appointed Chief Executive Officer of Rhythm, page-10
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $32.31M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.5¢ | $40.97K | 315.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6818 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 6362 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6818 | 0.125 |
5 | 160316 | 0.120 |
4 | 66192 | 0.115 |
3 | 122500 | 0.110 |
3 | 97616 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 6362 | 1 |
0.135 | 31506 | 2 |
0.140 | 101103 | 2 |
0.150 | 945959 | 4 |
0.155 | 23862 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online